Recombinant SARS-CoV-2 Envelope Protein
- SKU:
- RPCB2604
- Reactivity:
- SARS-CoV-2
- Tag:
- N-His & Avi
- Calculated MW:
- 11.02 kDa
- Observed MW:
- 12 kDa
- Application Area:
- Infectious Disease
Frequently bought together:
Description
| SKU: | RPCB2604 |
| Size: | 100 μg |
| Tag: | N-His & Avi |
| Reactivity: | SARS-CoV-2 |
| Protein Description: | Recombinant SARS-CoV-2(2019-nCoV) Envelope Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Val75) of SARS-COV-2(2019-nCoV) Envelope (Accession #QHD43418.1) fused with an initial Met,a 6×His,Avi tag at the N-terminus. |
| Endotoxin: | < 0.1 EU/μg of the protein by LAL method. |
| Purity: | ≥ 95 % as determined by SDS-PAGE. |
| Formulation: | Supplied as a 0.22 μm filtered solution in 20mM Tris,250mM NaCl,0.5%TritonX-100,pH 8.0.Contact us for customized product form or formulation. |
| Gene ID: | 43740570 |
| Storage: | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
| Swiss-Prot: | QHD43418.1 |
 | Recombinant SARS-CoV-2 Envelope Protein was determined by SDS- PAGE under reducing conditions with Coomassie Blue. |
 | Immobilized Recombinant SARS- CoV-2 Envelope at 2μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1. 2-41. 1 ng/mL. |
Related Products
